Davis, CA, United States of America

Raghavender Reddy Gopireddy

This inventor holds 1 USPTO granted patent. Top assignees: Goethe-University Frankfurt, University of California. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raghavender Reddy Gopireddy. Retrieved from https://idiyas.com/inventor/raghavender-reddy-gopireddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raghavender Reddy Gopireddy: Innovator in Dual Inhibitors

Introduction

Raghavender Reddy Gopireddy is a notable inventor based in Davis, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of dual inhibitors that target specific enzymes.

Latest Patents

Gopireddy holds a patent for "Orally available sEH/PDE4 dual inhibitors." This innovative patent describes novel bioavailable dual inhibitors capable of inhibiting both soluble epoxide hydrolase (sEH) and phosphodiesterase 4 (PDE4), along with methods for their use. His work in this area has the potential to impact therapeutic strategies significantly.

Career Highlights

Throughout his career, Gopireddy has been associated with prestigious institutions such as the University of California and Goethe University Frankfurt. His academic and research endeavors have positioned him as a key figure in his field.

Collaborations

Gopireddy has collaborated with esteemed colleagues, including Bruce D. Hammock and Rene Bloecher. These partnerships have furthered his research and contributed to the advancement of innovative solutions in pharmacology.

Conclusion

Raghavender Reddy Gopireddy's work exemplifies the spirit of innovation in the field of dual inhibitors. His contributions continue to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…